Basic Information
Basic information for C5orf64-220-31aa
Peptide Name C5orf64-220-31aa
Genome Position chr5:61758546-61758638[+]
Species Human
Peptide Sequence MKSTSQNPCVPTCGLFPCCLTLVKSLHLSVC
Peptide Length 31
Unique No (C5orf64-209-31aa,C5orf64-214-31aa,C5orf64-216-31aa,C5orf64-227-31aa,C5orf64-228-31aa)
Grand Average of Hydropathicity 0.6548
Relative Molecular Mass 3851.61
Experimental Evidences 1:ribo
lncRNA ID/Name ENSG00000178722;C5orf64
Transcript ID/Name ENST00000666908;C5orf64-220
Transcript Length 5095
Coding Ability 0.4118
DNA Sequence Corresponding to Peptide ATGAAGAGTACAAGCCAGAATCCCTGTGTCCCTACCTGTGGGCTTTTCCCTTGCTGCTTGACCTTAGTGAAGTCACTCCACCTCTCAGTCTGC
Experimental Evidences
   Occupancy of Ribosomes
Tissue :    
Expression type:    Count RPKM
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :